Home

Joseph Eid

CIK 1780247 · EVP, R&D; Chief Medical Office · last filed 2026-02-19

Joseph Eid is an EVP, R&D; Chief Medical Office who has filed 11 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for GERN, was dated Feb 19, 2026. Across all open-market trades the lifetime net is −$413.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $683.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$683.1K

Companies

2

Total Filings

11

Lifetime Open-Market Net

-$413.6K

Filer Profile

Reported Address
C/O GERON CORPORATION
919 EAST HILLSDALE BOULEVARD, SUITE 250
FOSTER CITY, CA 94404
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GERN EVP, R&D; Chief Medical Office — $1.57 — $0 2 2026-02-19
BMY SVP,Head Glob. Medical Affairs 10,223 $66.82 $683.1K -$413.6K 9 2021-06-04

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-19 GERN Grant (A) — $0 EDGAR
2024-11-12 GERN Grant (A) — $0 EDGAR
2021-06-04 BMY Mixed +1,416 -$47.8K EDGAR
2021-05-11 BMY Sell (S) −1,118 -$72.7K EDGAR
2021-03-12 BMY Mixed +4,796 -$133.6K EDGAR
2020-12-03 BMY Mixed +1,857 -$60.4K EDGAR
2020-08-19 BMY Sell (S) −5,327 -$340.9K EDGAR
2020-06-09 BMY Mixed +1,416 -$44.4K EDGAR
2020-03-12 BMY Mixed +1,118 -$36.8K EDGAR
2020-03-12 BMY Mixed +1,857 -$55.1K EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.